Extendicare (EXE) Investor Presentation summary
Event summary combining transcript, slides, and related documents.
Investor Presentation summary
25 Aug, 2025Strategic growth and market positioning
Largest seniors' care provider in Canada, focused on long-term care and home health care, with 57 years of experience and a strong acquisition pipeline in a fragmented market.
Over 90% of revenue is derived from government contracts, providing revenue stability and insulation from economic cycles.
Joint venture with Axium Infrastructure enables capital-efficient long-term care growth and redevelopment projects.
Significant demographic tailwinds, with the 85+ population expected to triple by 2051, driving demand for over 200,000 new LTC beds by 2035.
Services-focused model, with managed services and home health care representing over half of adjusted NOI.
Operational and financial performance
Q1 2025 revenue rose by $7.6M (2.1%) and NOI by $5.5M (12.3%), with AFFO per share up $0.025 (11.9%).
Home health care delivered 11M hours in 2024, with Q1 2025 ADV up 8.9% and NOI margin at a multi-year high of 11.6%.
Long-term care segment returned to pre-pandemic NOI and occupancy, with funding increases supporting margin improvement.
Managed services NOI up 55.3% over 2023, with consistent 50-55% margins and SGP network beds up 7.2% year-over-year.
Strong balance sheet with $218M available liquidity, 32% debt to GBV, and a ~50% payout ratio.
Growth initiatives and acquisitions
$75.5M acquisition of Closing the Gap expected to close in Q3 2025, adding $84.2M in revenue and $0.06 AFFO per share, with $1.1M in annualized cost synergies.
Agreement to acquire nine LTC homes from Revera, adding 822 LTC and 574 retirement beds, and increasing revenue and NOI by $109.3M and $6.8M, respectively.
Opened three new LTC homes since March 2024, commenced construction on three more, and completed sale of three projects to Axium JV, generating $56.3M in proceeds.
Pipeline of 18 LTC redevelopment projects, with six homes under construction and 12 more in planning.
Latest events from Extendicare
- Strong 2025 growth, 5% dividend hike, and $570M CBI Home Health deal closing in Q2 2026.EXE
Q4 202527 Feb 2026 - Q2 2024 delivered strong revenue, margin growth, and robust progress in redevelopment.EXE
Q2 20241 Feb 2026 - Double-digit revenue and margin growth, with enhanced liquidity and redevelopment progress.EXE
Q3 202414 Jan 2026 - Q4 2024 saw strong growth, margin gains, and a 5% dividend hike amid robust demand.EXE
Q4 20241 Dec 2025 - All proposals passed, with a 5% dividend hike and major growth and governance initiatives.EXE
AGM 202526 Nov 2025 - Q1 growth, margin gains, and acquisitions drive momentum amid strong sector demand.EXE
Q1 202526 Nov 2025 - Q2 2025 delivered 15.4% EBITDA growth and expansion from major acquisitions and home health care.EXE
Q2 202523 Nov 2025 - $570M deal creates Canada’s largest home health care platform, driving growth and efficiency.EXE
M&A Announcement20 Nov 2025 - Q3 2025 delivered 22.6% revenue growth and 40.6% higher EBITDA, led by acquisitions and home care.EXE
Q3 202515 Nov 2025